The Wendy’s Company (WEN)

Investigation 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Wendy’s Company (“Wendy’s” or the “Company”) (NASDAQ: WEN). Investors who purchased Wendy’s securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Wendy’s has violated federal securities laws.

On August 25, 2022, the Centers for Disease Control and Prevention (“CDC”) issued an investigation notice regarding a multistate outbreak of E. coli infections.  The notice reported that “37 people infected with the outbreak strain of coli O157 have been reported from 4 states: Indiana (1), Michigan (15), Ohio (19), and Pennsylvania (2)” and that “most sick people reported eating sandwiches with romaine lettuce at Wendy’s restaurants before getting sick.”  The CDC further stated that “[b]ased on the information collected so far, Wendy’s is taking the precautionary measure of removing the romaine lettuce being used in sandwiches from restaurants in that region.”  On this news, Wendy’s stock price fell $0.81 per share, or 4.01%, to close at $19.39 per share on August 26, 2022.

If you are aware of any facts relating to this investigation or purchased Wendy’s shares you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.